Alisporivir
- Generic Name
- Alisporivir
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C63H113N11O12
- CAS Number
- 254435-95-5
- Unique Ingredient Identifier
- VBP9099AA6
- Background
Alisporivir has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-08-17
- Last Posted Date
- 2016-08-25
- Lead Sponsor
- Debiopharm International SA
- Target Recruit Count
- 459
- Registration Number
- NCT01183169
- Locations
- 🇬🇧
Novartis Investigative Site, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath